Edition:
India

Molecular Templates Inc (MTEM.OQ)

MTEM.OQ on NASDAQ Stock Exchange Capital Market

8.30USD
22 Nov 2017
Change (% chg)

$0.34 (+4.27%)
Prev Close
$7.96
Open
$8.06
Day's High
$8.32
Day's Low
$7.80
Volume
36,339
Avg. Vol
32,497
52-wk High
$11.88
52-wk Low
$3.90

Chart for

About

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic... (more)

Overall

Beta: 3.09
Market Cap(Mil.): $59.10
Shares Outstanding(Mil.): 6.51
Dividend: --
Yield (%): --

Financials

BRIEF-Molecular Templates appoints Adam Cutler as CFO

* Molecular Templates strengthens management team with appointment of Adam Cutler as Chief Financial Officer

15 Nov 2017

BRIEF-Molecular Templates Q3 loss per share $0.62

* Molecular Templates, Inc. Reports third quarter 2017 financial results

15 Nov 2017

BRIEF-AbCheck and Molecular Templates collaborate to discover therapeutic oncology leads

* Says Abcheck will use Absieve discovery platform to deliver antibodies against biological targets selected by Molecular Templates​

25 Oct 2017

BRIEF-Molecular Templates files for sale of 11.6 mln shares of common stock by selling stockholders‍​

* Molecular Templates Inc - files for sale of 11.6 million shares of common stock by selling stockholders - sec filing‍​ Source text: (http://bit.ly/2x68onC) Further company coverage:

16 Sep 2017

BRIEF-Molecular Templates Inc files to say it raised $20 mln in equity financing‍​

* Molecular Templates Inc files to say it raised $20 million in equity financing‍​ Source text (http://bit.ly/2i1OaYC) Further company coverage:

15 Aug 2017

BRIEF-SHV Management Services reports 32.6 pct stake in Molecular Templates

* SHV Management Services reports 32.6 percent stake in molecular templates as of Aug 1 - SEC filing Source text: (http://bit.ly/2w4gAXS) Further company coverage:

15 Aug 2017

BRIEF-Takeda Pharmaceutical Co reports 10.9 pct stake in Molecular Templates - SEC Filing‍​

* Takeda Pharmaceutical Company reports 10.9 percent stake in Molecular Templates Inc as of August 1, 2017 - SEC Filing‍​ Source text: (http://bit.ly/2vTAtQL) Further company coverage:

11 Aug 2017

BRIEF-Takeda Pharmaceutical and Molecular Templates announce research and licensing collaboration

* Takeda Pharmaceutical and molecular templates announce multi-target research and licensing collaboration to develop next-generation oncology therapies​

03 Aug 2017

Competitors

Earnings vs. Estimates